Retrospective Data Collection for a Correlation Study Between Gastric Cancer and Clinical and Laboratory Variables (HP-RETROSS)
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
BO
-
Bologna, BO, Italy, 40138
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria cases:
- Età > 18 anni.
- Diagnosi istologica di carcinoma gastrico
- Ottenimento del consenso informato.
Inclusion criteria controls:
- Età > 18 anni.
- Esecuzione di indagine endoscopica gastrica con relativo esame istologico (mucosa sana, gastrite acuta, gastrite cronica con o senza infezione da Helicobacter pylori, metaplasia intestinale)
- Ottenimento del consenso informato.
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Collection of data
Time Frame: 2016-2020
|
The main objective of the study is to create a collection of clinical and laboratory data that will allow us to describe the incidence of gastric cancer in our center and to identify risk factors associated with the disease (H.
pylori infection, smoking, alcohol, diet and BMI).
|
2016-2020
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Data interaction in the developement of gastric cancer
Time Frame: 2016-2020
|
The secondary objective of the study is to know, analyze and describe the data collected in order to evaluate their possible interaction on the development of gastric neoplastic pathology, and to design a future prospective case-control study.
|
2016-2020
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Giulia Fiorini, MD, PhD, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HP-RETROSS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.